The central government has denied media reports claiming that the Ministry of Health and Family Welfare issued health ...

Ditch tobacco and limit alcohol. Smoking is strongly associated with colon cancer, says Lenz, so quitting tobacco is vital to ...

Since the onset of the COVID-19 pandemic, the prevalence of obesity in Canada has increased at a greater rate.

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

Carpal tunnel syndrome is twice as common in the 2 or more years preceding a diagnosis of rheumatoid arthritis, according to ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

The Ohio Department of Administrative Services announced state employees’ Medicaid coverage for GLP-1 obesity management ...

VYKAT XR launch generates $32M, addressing unmet Prader-Willi needs. Soleno (SLNO) stock fairly valued; potential buyout ...

In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is associated with superior weight loss outcomes, according to a study presented at ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presen ...

Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the most notable here.